Insulia type 2 diabetes App was developed by Voluntis. This App received FDA clearance and CE mark simultaneously. This App is designed for diabetes people under basal insulin medication. This prescription based device will be available during first half of 2017. Patients with diabetes can access this App via the web, tablet or smartphone and supports both iOS and Android operating systems. This App offers
Voluntis : Voluntis is a Paris based French company founded in 2001, pioneered in the development of therapeutic companion software. The company makes medical devices with high standards. The company provides innovative healthcare solutions in managing chronic health conditions such as
The company makes medical devices intended to provide personalized treatment solutions that coordinate of healthcare professionals. Along with AstraZeneca, Voluntis offers App based treatment solutions to ovarian cancer patients.
The Maine-Syracuse Longitudinal Study (MSLS) done by researchers from the University of South Australia and the University of Maine confirms that at least once in a week chocolate consumption lowers diabetes and lowers risk of the development of diabetes after four to five years. A total of 908 non-diabetic and 45 diabetic individuals participated in the MSLS study. The study results show
Researchers could not establish cause and relations between chocolate consumption and the development of diabetes. But researchers think cocoa flavanols found in dark chocolate are responsible for the health benefits. Previous studies done on chocolate consumption suggests one ounce (25 grams) of consumption per week may provide health benefits such as arterial stiffness (elasticity of the arteries) and better cognitive (mental) performance. The leader of the study is Georgina E Crichton, the University of South Australia and the study findings were published in The journal Appetite.
A Norwegian diet intervention study (FATFUNC) shows high saturated fat diet may not increase the risk of heart disease. Researchers studied risk with high saturated fat and low carbohydrates diet on 38 men with abdominal obesity over 12 weeks duration. The study indicates no difference between high fat and low carbohydrate diet after measuring fat mass in the liver, heart and abdominal areas. Ottar Nygrd, who contributed to this study says the calculated risk of cardiovascular diseases did not increase with the high consumption of total and saturated fat.
Researchers say high saturated fat and low carbohydrates diet improves health factors such as
Researchers say most of the healthy individual's body system may tolerate diet with high-quality saturated fat as long as total energy consumption is not high. They say future studies should find out who should limit the consumption of saturated fat. The leader of the study is Prof Simon Nitter Dankel and the study findings were published in The American Journal of Clinical Nutrition.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.